Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) Accumulated Depreciation & Amortization (2022 - 2023)

Lexeo Therapeutics' Accumulated Depreciation & Amortization history spans 2 years, with the latest figure at $316000.0 for Q3 2023.

  • For Q3 2023, Accumulated Depreciation & Amortization changed N/A year-over-year to $316000.0; the TTM value through Sep 2023 reached $316000.0, changed N/A, while the annual FY2022 figure was $133000.0, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization for Q3 2023 was $316000.0 at Lexeo Therapeutics, up from $133000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $316000.0 in Q3 2023 and bottomed at $133000.0 in Q4 2022.